Literature DB >> 16004935

Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in early gastric carcinoma: correlation with clinicopathological parameters.

Seiji Onogawa1, Yasuhiko Kitadai, Toru Amioka, Michiyo Kodama, Songde Cho, Tsuyoshi Kuroda, Takehiko Ochiumi, Shigeru Kimura, Toshio Kuwai, Shinji Tanaka, Kazuaki Chayama.   

Abstract

In this study, we investigated whether expression of vascular endothelial growth factor (VEGF)-C and/or VEGF-D correlates with clinicopathological features of human gastric carcinoma. We immunohistochemically examined the expression of VEGF-C and VEGF-D in 140 archival surgical specimens of submucosally invasive gastric carcinoma. Of these specimens, 32 (22.9%) and 12 (8.6%) showed intense VEGF-C and VEGF-D immunoreactivity in cancer cells, respectively. VEGF-C immunoreactivity was associated with histological type, lymphatic invasion, lymph node metastasis, and microvessel density. No association was identified between VEGF-D immunoreactivity and clinicopathological variables. These results suggest that VEGF-C is a dominant regulator of lymphangiogenesis in early-stage human gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16004935     DOI: 10.1016/j.canlet.2004.12.030

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

1.  Clinical validity of endoscopic submucosal dissection for submucosal invasive gastric cancer: a single-center study.

Authors:  Yoji Sanomura; Shiro Oka; Shinji Tanaka; Ikue Noda; Makoto Higashiyama; Hiroki Imagawa; Takayoshi Shishido; Shigeto Yoshida; Toru Hiyama; Koji Arihiro; Kazuaki Chayama
Journal:  Gastric Cancer       Date:  2011-07-23       Impact factor: 7.370

2.  Non-curative endoscopic resection does not always lead to grave outcomes in submucosal invasive early gastric cancer.

Authors:  Jun Young Choi; Seong Woo Jeon; Kwang Bum Cho; Kyung Sik Park; Eun Soo Kim; Chang Keun Park; Yun Jin Chung; Joong Goo Kwon; Jin Tae Jung; Eun Young Kim; Kyeong Ok Kim; Byung Ik Jang; Si Hyung Lee; Jeong Bae Park; Chang Hun Yang
Journal:  Surg Endosc       Date:  2014-10-08       Impact factor: 4.584

Review 3.  Role of the tumor microenvironment in the pathogenesis of gastric carcinoma.

Authors:  Hye Won Chung; Jong-Baeck Lim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 4.  Predicting lymph node status in early gastric cancer.

Authors:  Robert Michael Kwee; Thomas Christian Kwee
Journal:  Gastric Cancer       Date:  2008-09-30       Impact factor: 7.370

5.  The clinicopathological significance of tissue levels of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in gastric cancer.

Authors:  Seong-Eun Kim; Ki-Nam Shim; Sung-Ae Jung; Kwon Yoo; Joo Ho Lee
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

6.  Angiogenesis and lymphangiogenesis of gastric cancer.

Authors:  Yasuhiko Kitadai
Journal:  J Oncol       Date:  2010-03-29       Impact factor: 4.375

7.  Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.

Authors:  Xiao-Lei Wang; Jian-Ping Fang; Ru-Yong Tang; Xi-Mei Chen
Journal:  BMC Cancer       Date:  2010-06-17       Impact factor: 4.430

8.  Cancer-stromal cell interaction and tumor angiogenesis in gastric cancer.

Authors:  Yasuhiko Kitadai
Journal:  Cancer Microenviron       Date:  2009-12-18

9.  Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: a retrospective study of 61 cases.

Authors:  Yan Gu; Xiaoliang Qi; Shanyu Guo
Journal:  Clin Exp Metastasis       Date:  2008-05-30       Impact factor: 5.150

Review 10.  Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?

Authors:  Theodore D Tsirlis; George Papastratis; Kyriaki Masselou; Christos Tsigris; Antonis Papachristodoulou; Alkiviadis Kostakis; Nikolaos I Nikiteas
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.